
BCCOY
Healthcare · Medical Devices · $174.2M market cap
$0.61700.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 5, 2025 | Before the open | — | -0.08 | — |
| Nov 13, 2024 | Before the open | — | -0.08 | — |
| Aug 20, 2024 | Before the open | — | -0.03 | — |
| May 7, 2024 | Before the open | — | -0.01 | — |
| Feb 20, 2024 | Before the open | — | -0.30 | — |
| Sep 30, 2023 | Time not confirmed | — | -0.02 | — |
| Jun 30, 2023 | Time not confirmed | — | -0.30 | — |
| Mar 31, 2023 | Time not confirmed | — | -0.04 | — |
| Dec 31, 2022 | Time not confirmed | — | -0.32 | — |
| Sep 30, 2022 | Time not confirmed | — | 0.02 | — |
| Jun 30, 2022 | Time not confirmed | — | 0.02 | — |
| Mar 31, 2022 | Time not confirmed | — | -0.02 | — |
| Dec 31, 2021 | Time not confirmed | — | -0.01 | — |
| Sep 30, 2021 |
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on…
| Time not confirmed |
| — |
| -0.05 |
| — |